Home Options Trading Advantage Options – Shares of MannKind Soar on Product News

0 82

Shares of MannKind (MNKD) rose dramatically in trading on Thursday after the FDA made drug label changes for the company’s Afrezza drug. These changes will make it easier for the company to sell Afrezza by making it easier to market the drug. Shares of MNKD rose over +40.11% on the news and settled at 4.96 for the session. Keep an eye on the stock for further developments.

NO COMMENTS

Leave a Reply